Emmessar Biotech & Nutrition Limited (BOM:524768)
India · Delayed Price · Currency is INR 28.07
-0.47 (-1.65%)
At close: Jan 20, 2026
BOM:524768 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 3.76 | 6.11 | 5.55 | 10.19 | 3.65 | 69.91 | Upgrade |
Other Revenue | 16.29 | 15.24 | 14.86 | 14.96 | 14.08 | 14.66 | Upgrade |
| 20.06 | 21.35 | 20.42 | 25.15 | 17.73 | 84.56 | Upgrade | |
Revenue Growth (YoY) | -12.48% | 4.55% | -18.82% | 41.83% | -79.03% | 77.89% | Upgrade |
Cost of Revenue | 0.9 | 1.85 | 2 | 4.34 | 1.35 | 35.32 | Upgrade |
Gross Profit | 19.15 | 19.49 | 18.42 | 20.81 | 16.38 | 49.24 | Upgrade |
Selling, General & Admin | 10.22 | 9.75 | 10.06 | 8.71 | 8.02 | 6.38 | Upgrade |
Other Operating Expenses | 5.13 | 4.03 | 4.15 | 3.86 | 2.57 | 19.73 | Upgrade |
Operating Expenses | 16.34 | 14.76 | 15.18 | 13.5 | 11.52 | 26.7 | Upgrade |
Operating Income | 2.81 | 4.74 | 3.24 | 7.31 | 4.86 | 22.55 | Upgrade |
Interest Expense | -0.02 | -0.01 | - | - | - | - | Upgrade |
Interest & Investment Income | 4.83 | 4.83 | 4.9 | 2.41 | 2.09 | - | Upgrade |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.02 | -0.05 | -0.09 | - | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | -0 | - | - | - | Upgrade |
EBT Excluding Unusual Items | 7.64 | 9.58 | 8.12 | 9.67 | 6.87 | 22.55 | Upgrade |
Gain (Loss) on Sale of Investments | 0.01 | 0.01 | 0.01 | 0 | - | - | Upgrade |
Pretax Income | 7.65 | 9.58 | 8.13 | 9.67 | 9.32 | 22.55 | Upgrade |
Income Tax Expense | 5.31 | 6.42 | 0.63 | 4.63 | 4.56 | 8.05 | Upgrade |
Net Income | 2.34 | 3.16 | 7.5 | 5.04 | 4.75 | 14.5 | Upgrade |
Net Income to Common | 2.34 | 3.16 | 7.5 | 5.04 | 4.75 | 14.5 | Upgrade |
Net Income Growth | -72.96% | -57.82% | 48.79% | 5.97% | -67.21% | 92.35% | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade |
Shares Change (YoY) | 1.16% | - | - | - | -0.00% | - | Upgrade |
EPS (Basic) | 0.47 | 0.63 | 1.50 | 1.01 | 0.95 | 2.90 | Upgrade |
EPS (Diluted) | 0.44 | 0.61 | 1.48 | 1.01 | 0.95 | 2.90 | Upgrade |
EPS Growth | -74.58% | -58.78% | 46.77% | 5.97% | -67.21% | 92.35% | Upgrade |
Free Cash Flow | 1.28 | 2.24 | 6.45 | 3.5 | 19.64 | 4.66 | Upgrade |
Free Cash Flow Per Share | 0.25 | 0.45 | 1.29 | 0.70 | 3.93 | 0.93 | Upgrade |
Gross Margin | 95.49% | 91.32% | 90.21% | 82.75% | 92.38% | 58.23% | Upgrade |
Operating Margin | 14.03% | 22.19% | 15.87% | 29.07% | 27.43% | 26.66% | Upgrade |
Profit Margin | 11.66% | 14.81% | 36.72% | 20.03% | 26.81% | 17.14% | Upgrade |
Free Cash Flow Margin | 6.36% | 10.48% | 31.57% | 13.91% | 110.78% | 5.51% | Upgrade |
EBITDA | 3.8 | 5.71 | 4.22 | 8.25 | 5.79 | 23.12 | Upgrade |
EBITDA Margin | 18.96% | 26.77% | 20.64% | 32.79% | 32.64% | 27.34% | Upgrade |
D&A For EBITDA | 0.99 | 0.98 | 0.98 | 0.94 | 0.92 | 0.58 | Upgrade |
EBIT | 2.81 | 4.74 | 3.24 | 7.31 | 4.86 | 22.55 | Upgrade |
EBIT Margin | 14.03% | 22.19% | 15.87% | 29.07% | 27.43% | 26.66% | Upgrade |
Effective Tax Rate | 69.42% | 67.00% | 7.75% | 47.89% | 48.96% | 35.70% | Upgrade |
Revenue as Reported | 24.91 | 26.2 | 25.47 | 27.7 | 22.84 | 84.56 | Upgrade |
Advertising Expenses | - | 0.23 | 0.22 | 0.17 | 0.17 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.